4 ARM ORAL DOSE-RESPONSE TRIAL OF DOLASETRON MESYLATE (DM) FOR PREVENTION OF EMESIS INDUCED BY PLATINUM-CONTAINING MODERATELY EMETOGENIC CHEMOTHERAPY (CT)
T. Grote et al., 4 ARM ORAL DOSE-RESPONSE TRIAL OF DOLASETRON MESYLATE (DM) FOR PREVENTION OF EMESIS INDUCED BY PLATINUM-CONTAINING MODERATELY EMETOGENIC CHEMOTHERAPY (CT), European journal of cancer, 31A, 1995, pp. 1219-1219